The use of adenoviral vectors in gene therapy and vaccine approaches
Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...
主要な著者: | Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Sociedade Brasileira de Genética
2022-10-01
|
シリーズ: | Genetics and Molecular Biology |
主題: | |
オンライン・アクセス: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en |
類似資料
-
Development of novel vaccine vectors: Chimpanzee adenoviral vectors
著者:: Jingao Guo, 等
出版事項: (2018-07-01) -
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
著者:: Lynda Coughlan
出版事項: (2020-05-01) -
Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
著者:: Luca Scarsella, 等
出版事項: (2024-02-01) -
Improving adenoviral vectors and strategies for prostate cancer gene therapy
著者:: Rodrigo Esaki Tamura, 等
出版事項: (2018-08-01) -
DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
著者:: L. V. Cherenova, 等
出版事項: (2017-08-01)